ClearPoint Neuro, Inc. (CLPT) stock
Close on Nov 17, 2026Market cap $251.95MP/E –Yield –
Earnings
ClearPoint Neuro's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of ClearPoint Neuro's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 16, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | $12.10M | +36.0% | -$0.24 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 3, 2026after the close | $10.90M | +18.5% | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 13, 2026after the close | $12.10M | +42.4% | -$0.32 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 17, 2026after the close | $10.40M | +33.3% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $8.90M | +9.9% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025after the close | $9.20M | +16.5% | -$0.21 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025after the close | $8.50M | +11.8% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025after the close | $7.80M | +14.7% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | $8.10M | +39.7% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $7.90M | +31.7% | -$0.16 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024after the close | $7.60M | +40.7% | -$0.16 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 12, 2024after the close | $6.80M | +30.8% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023after the close | $5.80M | +13.7% | -$0.20 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023after the close | $6.00M | +15.4% | -$0.29 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023after the close | $5.40M | +8.0% | -$0.23 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023after the close | $5.20M | +20.9% | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | $5.10M | +10.9% | -$0.15 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022after the close | $5.20M | – | -$0.18 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022after the close | $5.00M | – | -$0.17 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 1, 2022after the close | $4.30M | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021after the close | $4.60M | – | -$0.18 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 10, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 11, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 4, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 10, 2020after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
ClearPoint Neuro's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | FY2026 | $48.00M – $50.00M | $52.00M – $56.00M | Lowered | Oct 28, 2026 |
| revenue | FY2026 | $48.00M – $52.00M | $52.00M – $56.00M | Lowered | Aug 3, 2026 |
Guidance vs results
The last range ClearPoint Neuro gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $36.00M – $38.00M | $37.00MΣ4Q | Within range |
Guidance history
Every forecast ClearPoint Neuro put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | revenue | FY2026 | $48.00M – $50.00M | Lowered |
| Aug 3, 2026 | revenue | FY2026 | $48.00M – $52.00M | Lowered |
| May 13, 2026 | revenue | FY2026 | $52.00M – $56.00M | Lowered |
| Mar 17, 2026 | revenue | FY2026 | $52.00M – $56.00M | New |
| Jan 12, 2026 | total revenues | FY2026 | $54.00M – $60.00M | Reaffirmed |
| Nov 6, 2025 | expected revenue | FY2025 | $36.00M – $38.00M | New |
| Nov 6, 2025 | total 2026 combined revenue | FY2026 | $54.00M – $60.00M | New |
| Aug 12, 2025 | revenue outlook | FY2025 | $36.00M – $41.00M | Reaffirmed |
| May 13, 2025 | revenue outlook | FY2025 | $36.00M – $41.00M | Reaffirmed |
| Feb 26, 2025 | growth | FY2025 | +15% – +31% | New |
| Feb 26, 2025 | revenue | FY2025 | $36.00M – $41.00M | New |
| Nov 7, 2024 | revenue | FY2024 | $30.00M – $33.00M | Reaffirmed |
| Aug 7, 2024 | revenue outlook | FY2024 | $30.00M – $33.00M | Raised |
| May 7, 2024 | revenue | FY2024 | $28.00M – $32.00M | Reaffirmed |
| Mar 12, 2024 | revenue guidance | FY2024 | $28.00M – $32.00M | Reaffirmed |
| Jan 8, 2024 | revenue | FY2024 | $28.00M – $32.00M | New |
| Nov 9, 2023 | total revenue | FY2023 | $23.00M – $25.00M | Lowered |
| Aug 8, 2023 | revenue outlook | FY2023 | $25.00M – $27.00M | Reaffirmed |
| May 11, 2023 | revenue | FY2023 | $25.00M – $27.00M | Reaffirmed |
| Mar 1, 2023 | revenue forecast | FY2023 | $25.00M – $27.00M | Reaffirmed |
| Jan 11, 2023 | revenue | FY2023 | $25.00M – $27.00M | New |
| Nov 8, 2022 | revenue | FY2022 | $21.00M – $22.00M | Reaffirmed |
| Aug 9, 2022 | revenue outlook | FY2022 | $21.00M – $22.00M | Reaffirmed |
| May 11, 2022 | revenue | FY2022 | $21.00M – $22.00M | Raised |
| Mar 1, 2022 | revenue | FY2022 | $20.00M – $22.00M | Reaffirmed |
| Feb 15, 2022 | revenue | FY2022 | $20.00M – $22.00M | New |
| Nov 9, 2021 | total case volume support | FY2021 | 900 – 1000 | New |
| Nov 9, 2021 | revenue | FY2021 | $16.00M – $17.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases ClearPoint Neuro filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
See a number that looks wrong?